• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

    Thumbnail
    View/ Open
    aging-03-192.PMC3091517.pdf (3.164Mb)

    Show full item record
    Author
    Steelman, Linda S.; Chappell, William H.; Abrams, Stephen L.; Kempf, C. Ruth; Long, Jacquelyn M.; Laidler, Piotr; Mijatovic, Sanja; Maksimovic-Ivanic, Danijela; Stivala, Franca; Mazzarino, Maria C.; Donia, Marco; Fagone, Paolo; Malaponte, Graziella; Nicoletti, Ferdinando; Libra, Massimo; Milella, Michele; Tafuri, Agostino; Bonati, Antonio; Bäsecke, Jörg; Cocco, Lucio; Evangelisti, Camilla; Martelli, Alberto M.; Montalto, Giuseppe; Cervello, Melchiorre; McCubrey, James A.
    Abstract
    Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways is often the result of genetic alterations in critical components in these pathways or upstream activators. Unrestricted cellular proliferation and decreased sensitivity to apoptotic-inducing agents are typically associated with activation of these pro-survival pathways. This review discusses the functions these pathways have in normal and neoplastic tissue growth and how they contribute to resistance to apoptotic stimuli. Crosstalk and commonly identified mutations that occur within these pathways that contribute to abnormal activation and cancer growth will also be addressed. Finally the recently described roles of these pathways in cancer stem cells, cellular senescence and aging will be evaluated. Controlling the expression of these pathways could ameliorate human health.
    URI
    http://hdl.handle.net/10342/5665
    Subject
     Raf; MEK; PI3K; mTOR; cancer; kinases; protein phosphorylation; signal transduction; apoptosis 
    Date
    2011-03
    Citation:
    APA:
    Steelman, Linda S., & Chappell, William H., & Abrams, Stephen L., & Kempf, C. Ruth, & Long, Jacquelyn M., & Laidler, Piotr, & Mijatovic, Sanja, & Maksimovic-Ivanic, Danijela, & Stivala, Franca, & Mazzarino, Maria C., & Donia, Marco, & Fagone, Paolo, & Malaponte, Graziella, & Nicoletti, Ferdinando, & Libra, Massimo, & Milella, Michele, & Tafuri, Agostino, & Bonati, Antonio, & Bäsecke, Jörg, & Cocco, Lucio, & Evangelisti, Camilla, & Martelli, Alberto M., & Montalto, Giuseppe, & Cervello, Melchiorre, & McCubrey, James A.. (March 2011). Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY), (3:3), p.192-222. Retrieved from http://hdl.handle.net/10342/5665

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Steelman, Linda S., and Chappell, William H., and Abrams, Stephen L., and Kempf, C. Ruth, and Long, Jacquelyn M., and Laidler, Piotr, and Mijatovic, Sanja, and Maksimovic-Ivanic, Danijela, and Stivala, Franca, and Mazzarino, Maria C., and Donia, Marco, and Fagone, Paolo, and Malaponte, Graziella, and Nicoletti, Ferdinando, and Libra, Massimo, and Milella, Michele, and Tafuri, Agostino, and Bonati, Antonio, and Bäsecke, Jörg, and Cocco, Lucio, and Evangelisti, Camilla, and Martelli, Alberto M., and Montalto, Giuseppe, and Cervello, Melchiorre, and McCubrey, James A.. "Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging". Aging (Albany NY). 3:3. (192-222.), March 2011. August 18, 2022. http://hdl.handle.net/10342/5665.
    Chicago:
    Steelman, Linda S. and Chappell, William H. and Abrams, Stephen L. and Kempf, C. Ruth and Long, Jacquelyn M. and Laidler, Piotr and Mijatovic, Sanja and Maksimovic-Ivanic, Danijela and Stivala, Franca and Mazzarino, Maria C. and Donia, Marco and Fagone, Paolo and Malaponte, Graziella and Nicoletti, Ferdinando and Libra, Massimo and Milella, Michele and Tafuri, Agostino and Bonati, Antonio and Bäsecke, Jörg and Cocco, Lucio and Evangelisti, Camilla and Martelli, Alberto M. and Montalto, Giuseppe and Cervello, Melchiorre and McCubrey, James A., "Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging," Aging (Albany NY) 3, no. 3 (March 2011), http://hdl.handle.net/10342/5665 (accessed August 18, 2022).
    AMA:
    Steelman, Linda S., Chappell, William H., Abrams, Stephen L., Kempf, C. Ruth, Long, Jacquelyn M., Laidler, Piotr, Mijatovic, Sanja, Maksimovic-Ivanic, Danijela, Stivala, Franca, Mazzarino, Maria C., Donia, Marco, Fagone, Paolo, Malaponte, Graziella, Nicoletti, Ferdinando, Libra, Massimo, Milella, Michele, Tafuri, Agostino, Bonati, Antonio, Bäsecke, Jörg, Cocco, Lucio, Evangelisti, Camilla, Martelli, Alberto M., Montalto, Giuseppe, Cervello, Melchiorre, McCubrey, James A.. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY). March 2011; 3(3) 192-222. http://hdl.handle.net/10342/5665. Accessed August 18, 2022.
    Collections
    • Microbiology and Immunology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback